Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
Higher percentage of patients with a pathological complete response also achieved with neoadjuvant nivolumab plus chemotherapy
Findings from the PEACE-1 study
New indication concerns the treatment of patients with differentiated thyroid carcinoma refractory or not eligible to radioactive iodine
Increased cancer risk among individuals with autism is likely attributable to co-occurring intellectual disability and/or birth defects
Evidence for efficacy is based on the results from the ZUMA-7 study
Findings from a phase III, AGILE study in patients with newly diagnosed IDH1-mutated acute myeloid leukaemia ineligible for induction chemotherapy
Findings from final prespecified overall survival analysis and an update on radiographic progression-free survival in the ARCHES study
It is intended for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies
Patients with mental illness significantly more likely to experience premature mortality
The estimates varied substantially by Sociodemographic Index quintile, highlighting global inequities in cancer burden
Findings from a multi-basket MyPathway study
It also approved gallium Ga 68 gozetotide, a radioactive diagnostic agent for PET of PSMA-positive lesions
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.
